The information on this site is not intended or implied to be a substitute for professional medical advice, diagnosis or treatment. Content within the patient forum is user-generated and has not been reviewed by medical professionals. Other sections of the Melanoma Research Foundation website include information that has been reviewed by medical professionals as appropriate. All medical decisions should be made in consultation with your doctor or other qualified medical professional.

matthat

Forum Replies Created

Viewing 0 reply threads
  • Replies
      matthat
      Participant
        i came here looking to get off my opdivo. ive been on it 18 months, i did a yervoy-opdivo combo to get rid of brain tumor in dec 2018. mri showed it was gone early april 2019. ive been on opdivo since, have some acid reflux issues and right eye jacked up somewhat. reading your story i go back and forth how long i want to stay on opdivo no less than 1 yr no more than 2. is what ive heard. and if it reoccurs i guess i could go back on it. congrats on your good news.
        matthat
        Participant
          Ive been on it for 19 months it cured my brain tumor at pons area for desmoplastic melanoma. right eye is effected some, and have some acid reflux issues from time to time. when is enoguh enough? I am thankfull for cure.
      Viewing 0 reply threads
      About the MRF Patient Forum

      The MRF Patient Forum is the oldest and largest online community of people affected by melanoma. It is designed to provide peer support and information to caregivers, patients, family and friends. There is no better place to discuss different parts of your journey with this cancer and find the friends and support resources to make that journey more bearable.

      The information on the forum is open and accessible to everyone. To add a new topic or to post a reply, you must be a registered user. Please note that you will be able to post both topics and replies anonymously even though you are logged in. All posts must abide by MRF posting policies.

      Popular Topics